Grants and Contributions:
Title:
Development of a unified antibody discovery and screening platform
Agreement Number:
1042870
Agreement Value:
$145,000.00
Agreement Date:
Apr 13, 2026 - Mar 31, 2027
Description:
The project will involve the development of a fully integrated antibody discovery platform that unifies the entire discovery workflow into a single continuous process embedding multi-parametric screening to accelerate the path to best-in-class therapeutic antibodies.
Organization:
National Research Council Canada
Expected Results:
The expected results and outcomes of NRC Industrial Research Assistance Program is focused on growing small and medium-sized enterprises (SMEs) through innovation and wealth creation for Canada.
Location:
Vancouver, British Columbia, CA V5T 0G9
Reference Number:
172-2026-2027-Q1-1042870
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
763972221
Recipient Type:
For-profit organization
Recipient's Operating Name:
Ascender Bioscience Inc
Recipient's Legal Name:
Ascender Bioscience Inc
Federal Riding Name:
Vancouver East
Federal Riding Number:
59035
Program:
Industrial Research Assistance Program
Program Purpose:
The purpose of Industrial Research Assistance Program Contributions to Firms is to provide support that assists small and medium-sized enterprises (SMEs) to advance their innovation knowledge and ability to innovate, grow through innovation and stimulate wealth creation for Canada.
Coverage:
Industrial Research Assistance Program projects stimulate wealth creation for Canada through technological innovation and strengthen Canadian innovation ecosystem by creating new industrial capacity.
NAICS Code:
541710